James M Ellison

Summary

Affiliation: Harvard Medical School
Country: USA

Publications

  1. ncbi request reprint Teaching collaboration between pharmacotherapist and psychotherapist
    James M Ellison
    Geriatric Psychiatry Program, McLean Hospital, 115 Mill St, Belmont, Massachusetts 02478, USA
    Acad Psychiatry 29:195-202. 2005
  2. ncbi request reprint Beyond the "C" in MCI: noncognitive symptoms in amnestic and non-amnestic mild cognitive impairment
    James M Ellison
    Geriatric Psychiatry Program, McLean Hospital, Belmont, MA 02478, USA
    CNS Spectr 13:66-72. 2008
  3. doi request reprint A 60-year-old woman with mild memory impairment: review of mild cognitive impairment
    James M Ellison
    Harvard Medical School, USA
    JAMA 300:1566-74. 2008
  4. doi request reprint Depression in later life: an overview with treatment recommendations
    James M Ellison
    Geriatric Psychiatry Program, SB322, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Psychiatr Clin North Am 35:203-29. 2012
  5. doi request reprint Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms
    Matthew R Woodward
    McLean Hospital Geriatric Psychiatry Research Program, Harvard Medical School, Belmont, MA Electronic address
    Am J Geriatr Psychiatry 22:415-9. 2014
  6. doi request reprint Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia
    Manjola Ujkaj
    Harvard South Shore Psychiatry Residency Training Program, Boston VA Healthcare System, Department of Psychiatry, Harvard Medical School, Brockton, MA 02301, USA
    Am J Geriatr Psychiatry 20:61-72. 2012
  7. pmc Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease
    Yosef A Berlow
    Geriatric Psychiatry Research Program, McLean Hospital, Belmont, MA, USA
    Int J Geriatr Psychiatry 25:780-8. 2010
  8. ncbi request reprint Mild cognitive impairment
    James M Ellison
    CNS Spectr 13:41-2. 2008

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Teaching collaboration between pharmacotherapist and psychotherapist
    James M Ellison
    Geriatric Psychiatry Program, McLean Hospital, 115 Mill St, Belmont, Massachusetts 02478, USA
    Acad Psychiatry 29:195-202. 2005
    ..This article addresses the teaching of collaborative pharmacotherapy to psychiatric residents...
  2. ncbi request reprint Beyond the "C" in MCI: noncognitive symptoms in amnestic and non-amnestic mild cognitive impairment
    James M Ellison
    Geriatric Psychiatry Program, McLean Hospital, Belmont, MA 02478, USA
    CNS Spectr 13:66-72. 2008
    ....
  3. doi request reprint A 60-year-old woman with mild memory impairment: review of mild cognitive impairment
    James M Ellison
    Harvard Medical School, USA
    JAMA 300:1566-74. 2008
    ..Discussion of her case reviews mild cognitive impairment with emphasis on an evidence-based approach to evaluation and treatment, including management of comorbid medical conditions, lifestyle changes, and pharmacotherapy...
  4. doi request reprint Depression in later life: an overview with treatment recommendations
    James M Ellison
    Geriatric Psychiatry Program, SB322, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Psychiatr Clin North Am 35:203-29. 2012
    ..Improved recognition and treatment of late-life depression holds great potential for improving physical and mental health in later life, reducing disability in later years, and improving quality of life...
  5. doi request reprint Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms
    Matthew R Woodward
    McLean Hospital Geriatric Psychiatry Research Program, Harvard Medical School, Belmont, MA Electronic address
    Am J Geriatr Psychiatry 22:415-9. 2014
    ..The efficacy of pharmacotherapeutic treatment options is modest. This study was conducted to explore the efficacy and safety of dronabinol as an adjunctive treatment for agitation and aggressive behavior in severely demented patients...
  6. doi request reprint Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia
    Manjola Ujkaj
    Harvard South Shore Psychiatry Residency Training Program, Boston VA Healthcare System, Department of Psychiatry, Harvard Medical School, Brockton, MA 02301, USA
    Am J Geriatr Psychiatry 20:61-72. 2012
    ..The authors examine the safety and efficacy of Electroconvulsive Therapy (ECT) for agitation and aggression in dementia patients...
  7. pmc Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease
    Yosef A Berlow
    Geriatric Psychiatry Research Program, McLean Hospital, Belmont, MA, USA
    Int J Geriatr Psychiatry 25:780-8. 2010
    ..To investigate the association of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD) and magnetic resonance imaging (MRI) measures of brain atrophy and white matter hyperintensities (WMH)...
  8. ncbi request reprint Mild cognitive impairment
    James M Ellison
    CNS Spectr 13:41-2. 2008